Downregulation of FANCD2 expression significantly inhibits the proliferation of esophageal cancer cells, affecting tumor formation and metastasis, and FANCD2 is a biomarker of esophageal cancer [43]. The gene discussed is FANCD2; the disease is esophageal cancer.